Abintus Bio Company

Abintus Bio engages in the field of in vivo immune cell reprogramming.
Technology: CAR-T therapy, Cell-based gene therapy, Others
Industry: Gene Therapy, Private
Headquarters: San Diego, California, United States
Founded Date: 2020-01-01
Employees Number: 1-10
Investors Number: 1
Total Funding: 13652623
Last Funding Date: 2022-08-15
Last Funding Type: Venture - Series Unknown

Visit Website
info@abintusbio.com
Register and Claim Ownership